HartmannWillner invites you to subscribe to our monthly newsletter. Each month we will offer original content relevant to the work in your field.
- FDA Interchangeability Guidance Part 2
- May 5th Marks the Deadline for INDs and DMFs
- Regenerative Medicine Advanced Therapy Designation: Regulatory Shortcuts for Market Approval
- FDA Will Not Delay the Implementation of the eCTD DMF Mandate Again
- Part 2: Roles and Responsibilities of the Primary Agencies that Regulate the Products of Biotechnology.